297 related articles for article (PubMed ID: 31864855)
1. Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host.
Le Roux D; Djokic V; Morisse S; Chauvin C; Doré V; Lagrée AC; Voisin D; Villain Y; Grasset-Chevillot A; Boursin F; Su C; Perrot S; Vallée I; Seche E; Blaga R
Vaccine; 2020 Feb; 38(6):1457-1466. PubMed ID: 31864855
[TBL] [Abstract][Full Text] [Related]
2. Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep.
Mévélec MN; Ducournau C; Bassuny Ismael A; Olivier M; Sèche E; Lebrun M; Bout D; Dimier-Poisson I
Vet Res; 2010; 41(4):49. PubMed ID: 20385082
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genotypes of Toxoplasma gondii in feline faeces (oocysts) and meat from sheep, cattle and pigs in Switzerland.
Berger-Schoch AE; Herrmann DC; Schares G; Müller N; Bernet D; Gottstein B; Frey CF
Vet Parasitol; 2011 May; 177(3-4):290-7. PubMed ID: 21183278
[TBL] [Abstract][Full Text] [Related]
4. Development of Toxoplasma gondii vaccine: A global challenge.
Verma R; Khanna P
Hum Vaccin Immunother; 2013 Feb; 9(2):291-3. PubMed ID: 23111123
[TBL] [Abstract][Full Text] [Related]
5. An experimental Toxoplasma gondii dose response challenge model to study therapeutic or vaccine efficacy in cats.
Cornelissen JB; van der Giessen JW; Takumi K; Teunis PF; Wisselink HJ
PLoS One; 2014; 9(9):e104740. PubMed ID: 25184619
[TBL] [Abstract][Full Text] [Related]
6. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts.
Dubey JP
Vet Parasitol; 2006 Aug; 140(1-2):69-75. PubMed ID: 16647212
[TBL] [Abstract][Full Text] [Related]
7. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine.
Mateus-Pinilla NE; Dubey JP; Choromanski L; Weigel RM
J Parasitol; 1999 Oct; 85(5):855-60. PubMed ID: 10577720
[TBL] [Abstract][Full Text] [Related]
8. Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii.
Freyre A; Choromanski L; Fishback JL; Popiel I
J Parasitol; 1993 Oct; 79(5):716-9. PubMed ID: 8410543
[TBL] [Abstract][Full Text] [Related]
9. Key Limitations and New Insights Into the
Mévélec MN; Lakhrif Z; Dimier-Poisson I
Front Cell Infect Microbiol; 2020; 10():607198. PubMed ID: 33324583
[TBL] [Abstract][Full Text] [Related]
10. Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route.
Garcia JL; Navarro IT; Biazzono L; Freire RL; da Silva Guimarães Junior J; Cryssafidis AL; Bugni FM; da Cunha IA; Hamada FN; Dias RC
Vet Parasitol; 2007 Apr; 145(3-4):197-206. PubMed ID: 17296268
[TBL] [Abstract][Full Text] [Related]
11. Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats.
Frenkel JK; Pfefferkorn ER; Smith DD; Fishback JL
Am J Vet Res; 1991 May; 52(5):759-63. PubMed ID: 1854103
[TBL] [Abstract][Full Text] [Related]
12. An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats.
Ramakrishnan C; Maier S; Walker RA; Rehrauer H; Joekel DE; Winiger RR; Basso WU; Grigg ME; Hehl AB; Deplazes P; Smith NC
Sci Rep; 2019 Feb; 9(1):1474. PubMed ID: 30728393
[TBL] [Abstract][Full Text] [Related]
13. Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice.
Ismael AB; Dimier-Poisson I; Lebrun M; Dubremetz JF; Bout D; Mevelec MN
J Infect Dis; 2006 Oct; 194(8):1176-83. PubMed ID: 16991094
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: A study of oocyst re-shedding in domestic cats.
Zulpo DL; Sammi AS; Dos Santos JR; Sasse JP; Martins TA; Minutti AF; Cardim ST; de Barros LD; Navarro IT; Garcia JL
Vet Parasitol; 2018 Jan; 249():17-20. PubMed ID: 29279081
[TBL] [Abstract][Full Text] [Related]
15. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
Dubey JP
Vet Parasitol; 2005 Nov; 133(4):289-98. PubMed ID: 16024176
[TBL] [Abstract][Full Text] [Related]
16. Mic1-3KO tachyzoite a live attenuated vaccine candidate against toxoplasmosis derived from a type I strain shows features of type II strain.
Moiré N; Dion S; Lebrun M; Dubremetz JF; Dimier-Poisson I
Exp Parasitol; 2009 Oct; 123(2):111-7. PubMed ID: 19508866
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats.
Shen Y; Zheng B; Sun H; Wu S; Fan J; Ding J; Gao M; Kong Q; Lou D; Ding H; Zhuo X; Lu S
Infect Dis Poverty; 2023 Jun; 12(1):60. PubMed ID: 37322556
[TBL] [Abstract][Full Text] [Related]
18. Schizogony and gametogony of oocyst-deficient T-263 strain of Toxoplasma gondii.
Dubey JP
Vet Parasitol; 2017 Oct; 245():160-162. PubMed ID: 28624132
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and epidemiology of Toxoplasma gondii oocyst shedding in domestic and wild felids.
Zhu S; Shapiro K; VanWormer E
Transbound Emerg Dis; 2022 Sep; 69(5):2412-2423. PubMed ID: 34153160
[TBL] [Abstract][Full Text] [Related]
20. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats.
Dubey JP
J Parasitol; 1995 Jun; 81(3):410-5. PubMed ID: 7776126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
